AKT1 and gastric cancer: Luteolin, another component of MO, which has been found to reduce gastric cancer cells growth and cancer metastasis in vitro and in vivo via regulating Notch1, PI3K, AKT, mTOR, ERK, STAT3, and P38 signaling pathways [36].